Tattoo marking breast tumors before chemo
Part of Cancer, Skin clinical trials.
This trial tests a simple method: marking the tumor with a small tattoo before chemotherapy. The tattoo helps surgeons find the exact spot for lumpectomy after the tumor shrinks, so you can keep more of your breast.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 75 years old.
- You have a confirmed breast cancer diagnosis (by biopsy).
- Your breast tumor is T2 or T3 size and you will receive chemotherapy before surgery.
- Doctors can feel your tumor, so they can mark it for tattooing.
- You are willing and able to have breast-conserving surgery (lumpectomy) after chemotherapy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether placing a tiny radioactive seed in your breast tumor before chemotherapy can help doctors see the best response and improve long-term outcomes. Participants get standard chemo plus the seed, and the study checks how often the tumor completely disappears.
This trial tests if a medical tattoo can replace standard marker tattoos for lining up radiation treatments. It aims to make the process safer and more comfortable for cancer patients.
This trial compares two methods to mark lymph nodes in the armpit after chemotherapy for breast cancer. It tests whether a carbon-based marker works as well as a metallic marker to help surgeons find and remove the right lymph nodes.
This study tests a special “marker” technique to help surgeons find affected lymph nodes in the armpit after chemotherapy. It may support more targeted surgery and help avoid unnecessary removal of healthy lymph nodes.
This study tests whether small disappearing ink marks can be used to guide daily radiation treatments for breast cancer. It may help make radiation more precise and comfortable.
This trial compares two techniques for pinpointing non-touchable breast cancer during breast-conserving surgery. The study aims to see which method is more accurate and whether it leads to better surgical outcomes.
Hear when a new Neoadjuvant Chemoimmunotherapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.